Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Published Research (Scientific Record) Foundational Mechanism 2003 Original PT-141 mechanism / clinical entry paper Molinoff, Shadiack, Earle, Diamond, and Quon described PT-141 as a synthetic peptide analogue of -MSH that is an agonist at MC3R and MC4R, expressed primarily in the central nervous system
Why Choose HDRx for Compounded Prescriptions: Accredited Pharmacy that supports high standards of quality and safety across compounded formulations
doi: 10.3945/jn.114.202408 238
Benefits of IV Glutathione Therapy for Lyme Disease In individuals with Lyme disease, oxidative stress and inflammation can overwhelm the bodys natural antioxidant defenses, leading to prolonged symptoms and greater damage
doi:10.1186/1471-2105-8-216
US$ 22.42
US$ 26.91
US$ 22.58
US$ 27.08
